News

NICE U-turns over obesity drug

27-Mar-08

NICE has recommended the use of rimonabant for the treatment of obese and overweight adults in England and Wales.

The final appraisal from NICE recommends the use of the drug as an adjunct to diet and exercise for individuals who have had an inadequate response to, are intolerant of, or are contraindicated to other anti-obesity medications.

The final guidance reverses the decision made by NICE in its draft technology appraisal, issued last December, that called for more information on how the drug compares with diet and exercise, orlistat and sibutramine to be made available before rimonabant could be recommended for use.

Obesity in England has more than trebled in the last two decades and the total socioeconomic cost of managing obesity and the conditions that it causes is estimated to be up to £7.4 billion per year.

sanjay.tanday@haymarket.com

Comment below and tell us what you think 


Comments

Kazzie

27/03/2008

It's not a U-turn.

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week